GASE
Generic Assessment of Side Effects in Clinical Trials
GASE is an instrument to assess side effects in clinical trials (e.g., drug trials). It supports the early detection of drug-induced adverse events. Side effects of GASE were selected according to FDA statistics and other sources. It is recommended to use GASE at baseline and during/after interventions. Reference data of the general population (n=2500) are available.
Versions of GASE (free download!):
a) Patient Self-rating (English version) (GASE_1_english_patient.pdf)
b) Structured Observer ratings (English version) (GASE_1_english_doctor.pdf)
c) Patient Self-rating (German version) (GASE_1_deutsch_Pat.pdf)
d) Structured Observer ratings (German version) (GASE_1_deutsch_Arzt.pdf)
Further Instructions, Background Information: Patient Self-rating (English version) (Instruction_GASE.pdf)
For commercial use (e.g., Industry sponsored trials), please contact rief@staff.uni-marburg.de
a) Patient Self-rating (English version) (GASE_1_english_patient.pdf)
b) Structured Observer ratings (English version) (GASE_1_english_doctor.pdf)
c) Patient Self-rating (German version) (GASE_1_deutsch_Pat.pdf)
d) Structured Observer ratings (German version) (GASE_1_deutsch_Arzt.pdf)
Further Instructions, Background Information: Patient Self-rating (English version) (Instruction_GASE.pdf)
For commercial use (e.g., Industry sponsored trials), please contact rief@staff.uni-marburg.de